Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial
Journal of Gynecologic Oncology · 2024
DOI: 10.3802/jgo.2024.35.e37 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Yoshifumi Takahashi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan. ytakahashi@jichi.ac.jp. Hauptthemen laut MEDLINE: Pulmonary Embolism, Genital Neoplasms, Female, Venous Thromboembolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Daiichi-Sankyo.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
OBJECTIVE: In Japan, perioperative prophylaxis of pulmonary embolism (PE) in gynecologic cancer patients with preoperative asymptomatic venous thromboembolism (VTE) has not been well established yet. The GOTIC-VTE trial was a prospective, multi-center, single-arm clinical trial to investigate the prevention of postoperative symptomatic PE onset by seamless anticoagulant therapy from the preoperative period to 4 weeks after surgery instead of using intermittent pneumatic compression. METHODS: Anticoagulant therapy was started immediately after asymptomatic VTE diagnosis and stopped preoperatively according to the rules of each institution. Unfractionated heparin administration was resumed within 12 hours postoperatively, and this was followed by the switch to low-molecular-weight heparin and subsequently, edoxaban; this cycle was continued for 28 days. Primary outcome was the occurrence of symptomatic PE in 28 days postoperatively. Secondary outcomes were the incidence of VTE-related events in 28 days and 6 months postoperatively and protocol-related adverse events. RESULTS: Between February 2018 and September 2020, 99 patients were enrolled; of these, 82 patients were assessed as the full analysis set, including 58 for ovarian cancer, fallopian tube, or peritoneal cancer; 21 for endometrial cancer; and 3 for cervical cancer. No symptomatic PE was observed within 28 days postoperatively; two patients had bleeding events (major bleeding and clinically relevant nonmajor bleeding) and three had grade 3 adverse events (increased alanine transaminase, aspartate aminotransferase, or gamma-glutamyl transferase). CONCLUSION: The multifaceted perioperative management for gynecologic malignancies with asymptomatic VTE effectively prevented postoperative symptomatic PE. TRIAL REGISTRATION: JRCT Identifier: jRCTs031180124.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan. ytakahashi@jichi.ac.jp.
- Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan.
- Department of Biostatistics, School of Medicine, Yokohama City University, Kanagawa, Japan.
- Department of Obstetrics and Gynecology, National Defense Medical College, Saitama, Japan.
- Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
ORCID-Profile: Yoshifumi Takahashi, Hiroyuki Fujiwara, Kouji Yamamoto, Masashi Takano, Morikazu Miyamoto, Kosei Hasegawa, Maiko Miwa, Toyomi Satoh, Hiroya Itagaki, Takashi Hirakawa, Mayuyo Mori-Uchino, Tomonori Nagai, Yoshinobu Hamada, Soichi Yamashita, Hiroko Yano, Tomoyasu Kato, Keiichi Fujiwara, Mitsuaki Suzuki
Förderung
- Daiichi-Sankyo
Zitieren
APA
Takahashi, Y., Fujiwara, H., Yamamoto, K., Takano, M., Miyamoto, M., Hasegawa, K., Miwa, M., Satoh, T., Itagaki, H., Hirakawa, T., Mori-Uchino, M., Nagai, T., Hamada, Y., Yamashita, S., Yano, H., Kato, T., Fujiwara, K., Suzuki, M., & GOTIC-VTE Trial Investigators (2024). Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2024.35.e37
Vancouver
Takahashi Y, Fujiwara H, Yamamoto K, Takano M, Miyamoto M, Hasegawa K, et al. Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. Journal of Gynecologic Oncology. 2024. doi:10.3802/jgo.2024.35.e37
BibTeX
@article{Takahashi2024,
author = {Takahashi, Yoshifumi and Fujiwara, Hiroyuki and Yamamoto, Kouji and Takano, Masashi and Miyamoto, Morikazu and Hasegawa, Kosei and Miwa, Maiko and Satoh, Toyomi and Itagaki, Hiroya and Hirakawa, Takashi and Mori-Uchino, Mayuyo and Nagai, Tomonori and Hamada, Yoshinobu and Yamashita, Soichi and Yano, Hiroko and Kato, Tomoyasu and Fujiwara, Keiichi and Suzuki, Mitsuaki and GOTIC-VTE Trial Investigators, GOTIC-VTE Trial Investigators},
title = {Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial},
journal = {Journal of Gynecologic Oncology},
year = {2024},
doi = {10.3802/jgo.2024.35.e37}
}
EUVIMED